Published in PLoS Genet on July 25, 2008
Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell Metab (2013) 2.17
Loss-of-function mutations of ILDR1 cause autosomal-recessive hearing impairment DFNB42. Am J Hum Genet (2011) 1.37
Differential 14-3-3 affinity capture reveals new downstream targets of phosphatidylinositol 3-kinase signaling. Mol Cell Proteomics (2009) 1.35
Dissociation of lipotoxicity and glucotoxicity in a mouse model of obesity associated diabetes: role of forkhead box O1 (FOXO1) in glucose-induced beta cell failure. Diabetologia (2010) 1.19
Positional cloning of zinc finger domain transcription factor Zfp69, a candidate gene for obesity-associated diabetes contributed by mouse locus Nidd/SJL. PLoS Genet (2009) 1.15
Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes. Curr Diabetes Rev (2014) 1.12
Positional cloning of a type 2 diabetes quantitative trait locus; tomosyn-2, a negative regulator of insulin secretion. PLoS Genet (2011) 1.10
Leptin receptor modulation of adiposity and fertility. Trends Endocrinol Metab (2009) 1.05
Molecular organization of tricellular tight junctions. Tissue Barriers (2014) 1.04
Genetic and epigenetic control of metabolic health. Mol Metab (2013) 1.03
Random mutagenesis of the mouse genome: a strategy for discovering gene function and the molecular basis of disease. Am J Physiol Gastrointest Liver Physiol (2010) 0.99
The apoptosis inhibitor ARC alleviates the ER stress response to promote β-cell survival. Diabetes (2012) 0.89
Congenic and bioinformatics analyses resolved a major-effect Fob3b QTL on mouse Chr 15 into two closely linked loci. Mamm Genome (2010) 0.86
Retinoic acid receptor signaling is required to maintain glucose-stimulated insulin secretion and β-cell mass. FASEB J (2014) 0.83
The genetic basis of obesity-associated type 2 diabetes (diabesity) in polygenic mouse models. Mamm Genome (2014) 0.81
Molecular basis for the regulation of islet beta cell mass in mice: the role of E-cadherin. Diabetologia (2013) 0.79
Insights into obesity and diabetes at the intersection of mouse and human genetics. Trends Endocrinol Metab (2014) 0.79
Single diabetic QTL derived from OLETF rat is a sufficient agent for severe diabetic phenotype in combination with leptin-signaling deficiency. Exp Diabetes Res (2012) 0.78
ILDR2: an endoplasmic reticulum resident molecule mediating hepatic lipid homeostasis. PLoS One (2013) 0.76
Use of Drosophila as an evaluation method reveals imp as a candidate gene for type 2 diabetes in rat locus Niddm22. J Diabetes Res (2015) 0.75
Altered pancreatic growth and insulin secretion in WSB/EiJ mice. PLoS One (2014) 0.75
Tricellular junctions: how to build junctions at the TRICkiest points of epithelial cells. Mol Biol Cell (2017) 0.75
The Protein Data Bank. Nucleic Acids Res (2000) 187.10
SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res (2003) 52.26
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science (2007) 51.70
Human non-synonymous SNPs: server and survey. Nucleic Acids Res (2002) 50.45
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science (2007) 43.16
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell (2007) 38.42
A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science (2007) 37.88
A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature (2007) 35.08
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol (1992) 34.17
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science (2007) 32.97
Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature (2005) 31.60
The Universal Protein Resource (UniProt). Nucleic Acids Res (2005) 23.66
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet (2006) 19.03
Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes (2003) 16.62
Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature (2004) 16.56
A pancreatic islet-specific microRNA regulates insulin secretion. Nature (2004) 15.02
Effective targeted gene 'knockdown' in zebrafish. Nat Genet (2000) 14.40
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet (2007) 13.28
Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes (1967) 11.63
Obesity and diabetes in the developing world--a growing challenge. N Engl J Med (2007) 10.54
Combining evolutionary information and neural networks to predict protein secondary structure. Proteins (1994) 9.97
SNAP: predict effect of non-synonymous polymorphisms on function. Nucleic Acids Res (2007) 8.46
The thrifty phenotype hypothesis. Br Med Bull (2001) 7.98
Islet beta cell failure in type 2 diabetes. J Clin Invest (2006) 7.67
Origins of prokaryotes, eukaryotes, mitochondria, and chloroplasts. Science (1978) 6.56
Pathogenesis of NIDDM. A balanced overview. Diabetes Care (1992) 6.56
The mosaic structure of variation in the laboratory mouse genome. Nature (2002) 6.54
Diet-induced type II diabetes in C57BL/6J mice. Diabetes (1988) 6.26
Strategies for mapping and cloning quantitative trait genes in rodents. Nat Rev Genet (2005) 5.57
CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem (1994) 5.51
Diabetes in identical twins. A study of 200 pairs. Diabetologia (1981) 5.02
Very slow turnover of beta-cells in aged adult mice. Diabetes (2005) 4.54
Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res (1985) 4.39
The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. Annu Rev Genomics Hum Genet (2003) 3.67
14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. Biochem J (2004) 3.60
New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell (2001) 3.52
An improved method for isolation of mouse pancreatic islets. Transplantation (1985) 3.52
Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes (1995) 3.47
Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol (2004) 3.45
A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet (2001) 3.26
An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet (1998) 3.16
Organ size is limited by the number of embryonic progenitor cells in the pancreas but not the liver. Nature (2007) 3.11
Inhibition of zebrafish fgf8 pre-mRNA splicing with morpholino oligos: a quantifiable method for gene knockdown. Genesis (2001) 3.04
Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Invest (2000) 3.01
Genome-wide natural antisense transcription: coupling its regulation to its different regulatory mechanisms. EMBO Rep (2006) 2.96
Prevalence of diabetes and impaired fasting glucose in adults--United States, 1999-2000. MMWR Morb Mortal Wkly Rep (2003) 2.60
Genetic epidemiology of diabetes. J Clin Invest (2005) 2.53
Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology (1997) 2.49
Formation of the digestive system in zebrafish. I. Liver morphogenesis. Dev Biol (2003) 2.48
Life and death of the pancreatic beta cells. Trends Endocrinol Metab (2000) 2.24
Nicotinamide nucleotide transhydrogenase: a key role in insulin secretion. Cell Metab (2006) 2.21
Deletion of nicotinamide nucleotide transhydrogenase: a new quantitive trait locus accounting for glucose intolerance in C57BL/6J mice. Diabetes (2006) 2.17
Vertebrate gene predictions and the problem of large genes. Nat Rev Genet (2003) 2.11
Formation of the digestive system in zebrafish. II. Pancreas morphogenesis. Dev Biol (2003) 2.10
Perspective: Postnatal pancreatic beta cell growth. Endocrinology (2000) 2.08
Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. J Biol Chem (2004) 2.05
A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: The Framingham Offspring Study. Diabetes (2002) 1.99
A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes (1999) 1.99
Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus. Nat Genet (2006) 1.97
beta-cell turnover: its assessment and implications. Diabetes (2001) 1.90
The genetic landscape of type 2 diabetes in mice. Endocr Rev (2006) 1.88
Insulin and obesity in the Zucker genetically obese rat "fatty". Endocrinology (1972) 1.88
Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia. J Biol Chem (2000) 1.85
14-3-3 proteins in cell cycle regulation. Semin Cancer Biol (2006) 1.83
Provisional mapping of quantitative trait loci modulating the acoustic startle response and prepulse inhibition of acoustic startle. Neuropsychopharmacology (2002) 1.77
Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes (2001) 1.75
A major effect QTL determined by multiple genes in epileptic EL mice. Genome Res (2000) 1.64
Evolutionary conserved role of ptf1a in the specification of exocrine pancreatic fates. Dev Biol (2004) 1.60
Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. Diabetes (2004) 1.54
Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. Obesity (Silver Spring) (2006) 1.52
Genetics of non-insulin-dependent (type-II) diabetes mellitus. Annu Rev Med (1996) 1.51
beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes (2001) 1.47
Concordance rate for type II diabetes mellitus in monozygotic twins: actuarial analysis. Diabetologia (1999) 1.47
The genetics of diabetes susceptibility in mice. FASEB J (1989) 1.40
Genetic control of susceptibility to infection with Mycobacterium tuberculosis in mice. Genes Immun (2000) 1.38
A catalog of stability-associated sequence elements in 3' UTRs of yeast mRNAs. Genome Biol (2005) 1.31
SORCS1: a novel human type 2 diabetes susceptibility gene suggested by the mouse. Diabetes (2007) 1.30
Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model. Proc Natl Acad Sci U S A (2001) 1.29
Differential requirement for ptf1a in endocrine and exocrine lineages of developing zebrafish pancreas. Dev Biol (2004) 1.26
Molecular cloning of a lipolysis-stimulated remnant receptor expressed in the liver. J Biol Chem (1999) 1.26
The search for type 2 diabetes susceptibility loci: the chromosome 1q story. Curr Diab Rep (2007) 1.22
Zebrafish pdx1 morphant displays defects in pancreas development and digestive organ chirality, and potentially identifies a multipotent pancreas progenitor cell. Genesis (2001) 1.21
Progress in sequencing the mouse genome. Genesis (2001) 1.20
Mapping of the mouse X chromosome using random genomic probes and an interspecific mouse cross. EMBO J (1985) 1.17
WFS1/wolframin mutations, Wolfram syndrome, and associated diseases. Hum Mutat (2001) 1.17
Exonic and intronic sequence variation in the human leptin receptor gene (LEPR). Diabetes (1997) 1.16
Glucose uptake, utilization, and signaling in GLUT2-null islets. Diabetes (2000) 1.12
Efficient and fast targeted production of murine models based on ENU mutagenesis. Mamm Genome (2005) 1.11
From genome to aetiology in a multifactorial disease, type 1 diabetes. Bioessays (1999) 1.11
Analysis of Ki-67 antigen expression, DNA proliferative fraction, and survival in resected cancer of the pancreas. Am J Surg (2003) 1.07
Genetic analysis of early endocrine pancreas formation in zebrafish. Mol Endocrinol (2005) 1.04
Insulin-like growth factor-I at physiological concentrations is a potent inhibitor of insulin secretion. Endocrinology (1990) 1.03
Speed congenics: accelerated genome recovery using genetic markers. Genet Res (1999) 1.03
Fishing for gene function--endocrine modelling in the zebrafish. J Endocrinol (2006) 1.01
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest (2005) 10.44
The long-term stability of the human gut microbiota. Science (2013) 5.15
De novo mutations in histone-modifying genes in congenital heart disease. Nature (2013) 5.15
The genomic sequence of the accidental pathogen Legionella pneumophila. Science (2004) 4.08
Human oocytes reprogram somatic cells to a pluripotent state. Nature (2011) 4.03
A public resource facilitating clinical use of genomes. Proc Natl Acad Sci U S A (2012) 3.72
Regulation of Fto/Ftm gene expression in mice and humans. Am J Physiol Regul Integr Comp Physiol (2008) 3.49
Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci U S A (2009) 3.43
Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J Clin Invest (2004) 3.23
Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation (2010) 3.13
Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL. Cancer Res (2009) 3.10
Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest (2005) 3.10
Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol Metab (2010) 2.79
Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab (2002) 2.76
Large erupting complex odontoma: a case report. J Can Dent Assoc (2007) 2.69
Functional analyses of variants reveal a significant role for dominant negative and common alleles in oligogenic Bardet-Biedl syndrome. Proc Natl Acad Sci U S A (2010) 2.45
Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli. J Clin Invest (2008) 2.44
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet (2013) 2.39
Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol (2009) 2.31
Effects of experimental weight perturbation on skeletal muscle work efficiency in human subjects. Am J Physiol Regul Integr Comp Physiol (2003) 2.28
Models of consent to return of incidental findings in genomic research. Hastings Cent Rep (2014) 2.25
Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension. Circ Cardiovasc Genet (2012) 2.16
Genetic testing preferences in families containing multiple individuals with epilepsy. Epilepsia (2014) 2.15
Is the energy homeostasis system inherently biased toward weight gain? Diabetes (2003) 2.14
Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. Am J Clin Nutr (2008) 2.13
Glycogen storage disease type III diagnosis and management guidelines. Genet Med (2010) 2.13
The motor neuron response to SMN1 deficiency in spinal muscular atrophy. Muscle Nerve (2014) 2.02
Transanal hemorrhoidal dearterialization: a systematic review. Dis Colon Rectum (2009) 2.01
11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls. J Nucl Med (2009) 1.99
Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics. Clin Cancer Res (2010) 1.92
EIF2AK4 mutations in pulmonary capillary hemangiomatosis. Chest (2014) 1.88
Waist Circumference and Cardiometabolic Risk: a Consensus Statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Obesity (Silver Spring) (2007) 1.87
Genetic loss of SH2B3 in acute lymphoblastic leukemia. Blood (2013) 1.87
Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies. Gastroenterology (2013) 1.83
Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9. Cardiovasc Res (2002) 1.83
Serum vitamin-D predicts insulin resistance in individuals with prediabetes. Indian J Med Res (2013) 1.81
Phylogeographic analysis of haplogroup E3b (E-M215) y chromosomes reveals multiple migratory events within and out of Africa. Am J Hum Genet (2004) 1.76
Responses of gut microbiota to diet composition and weight loss in lean and obese mice. Obesity (Silver Spring) (2011) 1.73
Tracing past human male movements in northern/eastern Africa and western Eurasia: new clues from Y-chromosomal haplogroups E-M78 and J-M12. Mol Biol Evol (2007) 1.69
To eat or not to eat - how the gut talks to the brain. N Engl J Med (2003) 1.68
A recurrent PDGFRB mutation causes familial infantile myofibromatosis. Am J Hum Genet (2013) 1.66
A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders. J Med Genet (2012) 1.63
Copy-number disorders are a common cause of congenital kidney malformations. Am J Hum Genet (2012) 1.63
High prevalence of BRCA1 and BRCA2 germline mutations with loss of heterozygosity in a series of resected pancreatic adenocarcinoma and other neoplastic lesions. Clin Cancer Res (2013) 1.63
Robust singular value decomposition analysis of microarray data. Proc Natl Acad Sci U S A (2003) 1.58
Natriuretic peptides: Diagnostic and therapeutic use. Indian J Endocrinol Metab (2011) 1.57
A mutation in the leptin receptor is associated with Entamoeba histolytica infection in children. J Clin Invest (2011) 1.55
Rosiglitazone induces mitochondrial biogenesis in mouse brain. J Alzheimers Dis (2007) 1.53
Mechanism and management of AKT inhibitor-induced hyperglycemia. Clin Cancer Res (2009) 1.53
Bioinformatics for personal genome interpretation. Brief Bioinform (2012) 1.51
Reprogramming within hours following nuclear transfer into mouse but not human zygotes. Nat Commun (2011) 1.49
Researchers' views on return of incidental genomic research results: qualitative and quantitative findings. Genet Med (2013) 1.48
Processing, distribution, and function of VGF, a neuronal and endocrine peptide precursor. Cell Mol Neurobiol (2004) 1.47
Variants of the CFC1 gene in patients with laterality defects associated with congenital cardiac disease. Cardiol Young (2007) 1.47
Human Y chromosome haplogroup R-V88: a paternal genetic record of early mid Holocene trans-Saharan connections and the spread of Chadic languages. Eur J Hum Genet (2010) 1.47
Dietary fat is not a major determinant of body fat. Am J Med (2002) 1.46
Determinants of leptin gene expression in fat depots of lean mice. Am J Physiol Regul Integr Comp Physiol (2002) 1.45
Mutations in ZIC3 and ACVR2B are a common cause of heterotaxy and associated cardiovascular anomalies. Cardiol Young (2011) 1.44
Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics. J Gen Physiol (2013) 1.44
Comparison of endoscopic and clinical characteristics of patients with familial and sporadic Barrett's esophagus. Dig Dis Sci (2011) 1.43
Myxedema coma: a new look into an old crisis. J Thyroid Res (2011) 1.42
Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND). Pediatr Phys Ther (2011) 1.42
Novel splice mutation in microthalmia-associated transcription factor in Waardenburg Syndrome. Genet Test Mol Biomarkers (2011) 1.39
Primary carcinoids of the liver: a review of symptoms, diagnosis and treatments. Dig Surg (2008) 1.35
Body fat redistribution after weight gain in women with anorexia nervosa. Am J Clin Nutr (2005) 1.34
Genetic testing for dilated cardiomyopathy in clinical practice. J Card Fail (2012) 1.32
Prospective cohort study of spinal muscular atrophy types 2 and 3. Neurology (2012) 1.31
Association of functionally significant Melanocortin-4 but not Melanocortin-3 receptor mutations with severe adult obesity in a large North American case-control study. Hum Mol Genet (2008) 1.30
Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society. Circulation (2015) 1.30
Monoclonal antibody antagonists of hypothalamic FGFR1 cause potent but reversible hypophagia and weight loss in rodents and monkeys. Am J Physiol Endocrinol Metab (2006) 1.27
Cut-like homeobox 1 (CUX1) regulates expression of the fat mass and obesity-associated and retinitis pigmentosa GTPase regulator-interacting protein-1-like (RPGRIP1L) genes and coordinates leptin receptor signaling. J Biol Chem (2010) 1.26
Metabolic syndrome in South Asians. Indian J Endocrinol Metab (2012) 1.24
iPSC-derived β cells model diabetes due to glucokinase deficiency. J Clin Invest (2013) 1.23
Energy intake in weight-reduced humans. Brain Res (2010) 1.21
Challenges and opportunities of defining clinical leptin resistance. Cell Metab (2012) 1.21
Collective judgment predicts disease-associated single nucleotide variants. BMC Genomics (2013) 1.20
Leptin reverses declines in satiation in weight-reduced obese humans. Am J Clin Nutr (2012) 1.19
β-cell dysfunction due to increased ER stress in a stem cell model of Wolfram syndrome. Diabetes (2013) 1.19
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2012) 1.17
Leptin administration does not prevent the bone mineral metabolism changes induced by weight loss. Metabolism (2011) 1.17
Effects of obesity on the relationship of leptin mRNA expression and adipocyte size in anatomically distinct fat depots in mice. Am J Physiol Regul Integr Comp Physiol (2004) 1.17
SNPdbe: constructing an nsSNP functional impacts database. Bioinformatics (2011) 1.16
GI262570, a peroxisome proliferator-activated receptor {gamma} agonist, changes electrolytes and water reabsorption from the distal nephron in rats. J Pharmacol Exp Ther (2004) 1.16
Better prediction of functional effects for sequence variants. BMC Genomics (2015) 1.16
Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats. Am J Physiol Endocrinol Metab (2005) 1.14
The genetic basis of pulmonary arterial hypertension. Hum Genet (2014) 1.14
Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine. J Endocrinol (2008) 1.13
Defining a comprehensive verotype using electronic health records for personalized medicine. J Am Med Inform Assoc (2013) 1.13
Common variants in the CD36 gene are associated with oral fat perception, fat preferences, and obesity in African Americans. Obesity (Silver Spring) (2012) 1.13